How it works
Learn how research & development works at Novartis Oncology. »
Local websites
General contact
Head Office
Novartis International AG
CH-4002 Basel
Switzerland
+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)
Investors
Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland
+41 61 324 79 44
investor.relations@novartis.com
Media
Global Oncology Media Relations
Denise Brashear
Novartis Oncology Global Public Relations
+1 862 778 7336
Denise.Brashear@novartis.com
Novartis Media Relations
Eric Althoff
Basel, Switzerland
+41 61 324 7999
eric.althoff@novartis.com
pane 4 content
This site is not intended for U.S. residents.
Accelerating development
of medicines with potential
for greater patient benefit
Open
Research & Development
Together, we explore novel compounds in clinical development, many with potential best-in-class status, aiming to advance or create new
standards of care.
Pipeline
See compounds in all phases of development, from preclinical studies through large, randomized Phase III trials.
Explore our interactive pipeline
Clinical Trials
Novartis is currently conducting clinical trials in a number of disease areas. Learn more
